Product Name: Ibrutinib
Brand Name: Imbruvica
CAS No.: 936563-96-1
Purity: ≥99.0%
Category: API (Active Pharmaceutical Ingredient)
Shelf Life: 1 year
Storage: Room temperature, protect from light
Manufacturer: Janssen (USA)

Description:
Ibrutinib is a novel kinase inhibitor approved by the FDA for the treatment of:

1. Mantle Cell Lymphoma (MCL) in patients who have received at least one prior therapy

2. Chronic Lymphocytic Leukemia (CLL) in previously treated patients

Note: Generally well-tolerated, but long-term use may lead to adverse effects such as nail and hair abnormalities.

Keywords: 936563-96-1; Ibrutinib; Imbruvica; Ibrutinib Capsules